Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EROAD Limited Director's Dealing 2018

Mar 14, 2018

66188_rns_2018-03-14_e4f3f15d-4e6d-43e7-be7d-5ce125f24588.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [91 x 25] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and Name of listed issuer: Date this disclosure made: Date of last disclosure:

Director or senior manager giving disclosure Full name(s): Name of listed issuer: Name of related body corporate (if applicable): Position held in listed issuer:

EROAD Limited 13-Mar-18 N/A Graham Stuart EROAD Limited Not applicable Director

Summary of acquisition or disposal of relevant interest(excluding specified Summary of acquisition or disposal of relevant interest(excluding specified derivatives)
Class of affected quoted financial products: Ordinary Shares in EROAD Limited
(ERD)
Nature of the affected relevant interest(s): Registered holder and beneficial owner
For that relevant interest-
Number held in class before acquisition or disposal: 0
Number held in class after acquisition or disposal: 20,000

Current registered holder(s):
Graham Robert Stuart & Nicola
Roberta Stuart
Registered holder(s) once transfers are registered: Not applicable
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative: Not applicable
Class of underlying financial products: Not applicable
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of
underlying financial products (if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled: Not applicable
Maturity date of the derivative (if any): Not applicable
Expiry date of the derivative(if any): Not applicable
The price specified in the terms of the derivative (if any): Not applicable
Any other details needed to understand how the amount of the consideration
payable under the derivative or the value of the derivative is affected by the
value of the underlying financial products:
Not applicable
For that derivative,-
Parties to the derivative: Not applicable
If the director or senior manager is not a party to the derivative, the nature of
the relevant interest in the derivative:
Not applicable
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 2
Details of transactions requiring disclosure-
Date of transaction:
Nature of transaction:
Name of anyotherpartyorparties to the transaction(if known):
The consideration,expressed in New Zealand dollars, paid or received for the
Number of financialproducts to which the transaction related:
If the issuer has a financial products trading policy that prohibits directors or
senior managers from trading during any period without written clearance (a
closed period) include the following details—
Whether relevant interests were acquired or disposed of duringa closed
Details of transactions requiring disclosure-
Date of transaction:
Nature of transaction:
Name of anyotherpartyorparties to the transaction(if known):
The consideration,expressed in New Zealand dollars, paid or received for the
Number of financialproducts to which the transaction related:
If the issuer has a financial products trading policy that prohibits directors or
senior managers from trading during any period without written clearance (a
closed period) include the following details—
Whether relevant interests were acquired or disposed of duringa closed
Date of transaction: 8 March 2018 9 March 2018
Nature of transaction: On market purchase of 19,964 EROAD
ordinary shares
On market purchase of 36 EROAD
ordinary shares
Name of anyotherpartyorparties to the transaction(if known): Unknown Unknown
The consideration,expressed in New Zealand dollars, paid or received for the $69,674.36 $125.64
Number of financialproducts to which the transaction related: 19,964 36
If the issuer has a financial products trading policy that prohibits directors or
senior managers from trading during any period without written clearance (a
closed period) include the following details—
No
Not applicable
Not applicable
Whether relevant interests were acquired or disposed of duringa closed No
Whether prior written clearance was provided to allow the acquisition or Not applicable
Date of the prior written clearance (if any): Not applicable

Summary of other relevant interests after acquisition or disposal:

Summary of other relevant interests after acquisition or disposal:
Class ofquoted financialproducts: Not applicable
Nature of relevant interest: Not applicable
_For that relevant interest,- _
Number held in class: Not applicable
Current registered holder(s): Not applicable
For a derivative relevant interest,-
Type of derivative: Not applicable
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of
underlying financial products (if any): Not applicable
A statement as to whether the derivative is cash settled or physically settled: Not applicable
Maturity date of the derivative (if any): Not applicable
Expiry date of the derivative (if any): Not applicable
The price's specified terms (if any): Not applicable
Any other details needed to understand how the amount of the consideration
payable under the derivative or the value of the derivative is affected by the
value of the underlying financial products: Not applicable
For that derivative relevant interest,- Not applicable
Parties to the derivative: Not applicable
If the director or senior manager is not a party to the derivative, the nature of
the relevant interest in the derivative: Not applicable

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.

Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person:

13-Mar-18 Mark Heine, EVP, General Counsel